National Guideline Clearinghouse | Dapagliflozin in combination therapy for treating type 2 diabetes.

full-text ►

National Guideline Clearinghouse | Dapagliflozin in combination therapy for treating type 2 diabetes.



National Institute for Health and Care Excellence (NICE)

January 27, 2014

Guideline Title

Dapagliflozin in combination therapy for treating type 2 diabetes.

Bibliographic Source(s)

National Institute for Health and Care Excellence (NICE). Dapagliflozin in combination therapy for treating type 2 diabetes. London (UK): National Institute for Health and Care Excellence (NICE); 2013 Jun. 61 p. (Technology appraisal guidance; no. 288).

Guideline Status

This is the current release of the guideline.